AACR Annual Meeting to Be Held Next Month
Posted on: Tuesday, 28 March 2006, 15:00 CST
World-renowned scientists are expected in Washington April 1-5 for the 97th Annual Meeting of the American Association for Cancer Research.
The meeting of about 16,000 scientists, physicians, academicians and advocates from around the world will include presentations focusing on the latest findings in laboratory, translational and clinical cancer research.
We are at a critical juncture in the field of cancer research and the exchange of scientific information has taken on a greater urgency, said Peter Jones, president of the AACR. With pending cuts to the research budget of the National Institutes of Health, and specifically the National Cancer Institute, the free-flow of information shared amongst researchers and oncologists at the AACR Annual Meeting has never played a greater role in advancing the field.
Dr. Daniel Haber, chairman of the meeting's program committee, said the accelerating pace of cancer research discoveries is unprecedented.
The rapid progress in our understanding of different types of cancer at the molecular level is now starting to bear fruit and it will have a very significant impact on our ability to treat and hopefully prevent these diseases.
Source: United Press International
Related Articles
- Mersana's Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
- Medarex Reports Interim Data From Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
- Spectrum Pharmaceuticals Presents Data on SPI-1620, a Novel Adjunct to Chemotherapy, at the American Association of Cancer Research Meeting
- Genasense(R) Mechanisms of Action With Chemotherapy and Radiation Featured at Cancer Research Meeting
- Sunesis Presents Data on Anti-Cancer Compound SNS-032 at American Association for Cancer Research Meeting
- Sunesis Presents Results From Phase I Clinical and Preclinical Studies of SNS-595 at American Association for Cancer Research Meeting
- Preclinical Data on ARIAD's Molecularly Targeted Oncology Programs to Be Presented at the American Association for Cancer Research Meeting
- AVI BioPharma Presents Positive Results With NEUGENE Antisense Drugs At the American Association for Cancer Research Meeting
- Medarex Announces Upcoming Presentations at American Association for Cancer Research Meeting
- Sunesis Presents Data on Novel Anti-Cancer Drug at American Association of Cancer Research Meeting
 |
 |
User Comments (0)
RSS Feeds